Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc operates in various business sectors.
Market Cap & Net Worth: Amphastar Pharmaceuticals Inc (29A)
Amphastar Pharmaceuticals Inc (STU:29A) has a market capitalization of $148.68K (€144.84K) as of March 19, 2026. Listed on the STU stock exchange, this Germany-based company holds position #40130 globally and #5815 in its home market, demonstrating a -8.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Amphastar Pharmaceuticals Inc's stock price €15.63 by its total outstanding shares 9270 (9.27K).
Amphastar Pharmaceuticals Inc Market Cap History: 2019 to 2026
Amphastar Pharmaceuticals Inc's market capitalization history from 2019 to 2026. Data shows change from $158.91K to $148.68K (-3.80% CAGR).
Amphastar Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Amphastar Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Amphastar Pharmaceuticals Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Amphastar Pharmaceuticals Inc's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $158.91K | $334.01 Million | $4.04 Million | 0.00x | 0.04x |
| 2020 | $149.39K | $349.85 Million | $1.40 Million | 0.00x | 0.11x |
| 2021 | $187.45K | $437.77 Million | $62.12 Million | 0.00x | 0.00x |
| 2022 | $251.21K | $498.99 Million | $91.39 Million | 0.00x | 0.00x |
| 2023 | $518.59K | $644.39 Million | $137.54 Million | 0.00x | 0.00x |
Competitor Companies of 29A by Market Capitalization
Companies near Amphastar Pharmaceuticals Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Amphastar Pharmaceuticals Inc by market ranking:
- CANADIAN SOLAR - Dusseldorf Stock Exchang (DU:L5A): Ranked #40121 globally with a market cap of $147.80K USD ( €143.99K EUR).
- BENZ (NEO:BENZ): Ranked #40122 globally with a market cap of $147.64K USD ( CA$212.04K CAD).
- PG&E (PCG.SG) (STU:PCG): Ranked #40131 globally with a market cap of $147.16K USD ( €143.36K EUR).
- CELLAVISION (BE:C26): Ranked #40132 globally with a market cap of $147.12K USD ( €143.32K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #40121 | CANADIAN SOLAR - Dusseldorf Stock Exchang | DU:L5A | $147.80K | €15.68 |
| #40122 | BENZ | NEO:BENZ | $147.64K | CA$23.23 |
| #40131 | PG&E (PCG.SG) | STU:PCG | $147.16K | €15.60 |
| #40132 | CELLAVISION | BE:C26 | $147.12K | €14.40 |
Amphastar Pharmaceuticals Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Amphastar Pharmaceuticals Inc's market cap moved from $158.91K to $ 148.68K, with a yearly change of -3.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €148.68K | -29.59% |
| 2025 | €211.15K | -37.17% |
| 2024 | €336.08K | -35.19% |
| 2023 | €518.59K | +106.44% |
| 2022 | €251.21K | +34.01% |
| 2021 | €187.45K | +25.48% |
| 2020 | €149.39K | -5.99% |
| 2019 | €158.91K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Amphastar Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $148.68K USD |
| MoneyControl | $148.68K USD |
| MarketWatch | $148.68K USD |
| marketcap.company | $148.68K USD |
| Reuters | $148.68K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.